MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
18.14
+0.45 (2.54%)
At close: Mar 4, 2026, 4:00 PM EST
18.20
+0.06 (0.33%)
After-hours: Mar 4, 2026, 7:17 PM EST
MLTX Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for MLTX stock have an average target of 25.7, with a low estimate of 5.00 and a high estimate of 61. The average target predicts an increase of 41.68% from the current stock price of 18.14.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for MLTX stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 3 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 2 | 2 | 2 |
| Total | 9 | 9 | 9 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $12 → $13 | Hold | Maintains | $12 → $13 | -28.34% | Mar 2, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $32 → $40 | Strong Buy | Maintains | $32 → $40 | +120.51% | Mar 2, 2026 |
| Needham | Needham | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +37.82% | Feb 26, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $30 → $35 | Buy | Maintains | $30 → $35 | +92.94% | Feb 24, 2026 |
| BTIG | BTIG | Strong Buy Maintains $24 → $30 | Strong Buy | Maintains | $24 → $30 | +65.38% | Feb 23, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
22.67M
EPS This Year
-3.69
from -3.53
EPS Next Year
-3.74
from -3.69
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | n/a | 43.6M | |||
| Avg | n/a | 22.7M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -2.66 | -2.73 | |||
| Avg | -3.69 | -3.74 | |||
| Low | -4.16 | -5.10 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.